Repaglinide
- Product NDC
- 62135-947
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Repaglinide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA078555
- Marketing category
- ANDA
- Substance
- REPAGLINIDE
- Current FDA listing
- Yes
Related Records
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|---|---|---|---|---|
| 62135-947-90 | 90 TABLET in 1 BOTTLE (62135-947-90) | 2025-04-24 | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|---|---|---|---|
| Repaglinide | Chartwell RX, LLC | 2025-05-02 | HUMAN PRESCRIPTION DRUG LABEL | 1 |